E-resources
-
Lai, Eleonora; Liscia, Nicole; Donisi, Clelia; Mariani, Stefano; Tolu, Simona; Pretta, Andrea; Persano, Mara; Pinna, Giovanna; Balconi, Francesca; Pireddu, Annagrazia; Impera, Valentino; Dubois, Marco; Migliari, Marco; Spanu, Dario; Saba, Giorgio; Camera, Silvia; Musio, Francesca; Ziranu, Pina; Puzzoni, Marco; Demurtas, Laura; Pusceddu, Valeria; Dettori, Manuela; Massa, Elena; Atzori, Francesco; Dessì, Mariele; Astara, Giorgio; Madeddu, Clelia; Scartozzi, Mario
Cancers, 05/2020, Volume: 12, Issue: 5Journal Article
Metastatic CRC (mCRC) is a molecular heterogeneous disease. The aim of this review is to give an overview of molecular-driven treatment of mCRC patients. A review of clinical trials, retrospective studies and case reports was performed regarding molecular biomarkers with therapeutic implications. wild-type status was confirmed as being crucial for anti-epidermal growth factor receptor (EGFR) monoclonal antibodies and for rechallenge strategy. Antiangiogenic therapies improve survival in first- and second-line settings, irrespective of status, while tyrosine kinase inhibitors (TKIs) remain promising in refractory mCRC. Promising results emerged from anti-HER2 drugs trials in HER2-positive mCRC. Target inhibitors were successful for mutant mCRC patients, while immunotherapy was successful for microsatellite instability-high/defective mismatch repair (MSI-H/dMMR) or DNA polymerase epsilon catalytic subunit ( ) mutant patients. Data are still lacking on , and TGF-β, which require further research. Several molecular biomarkers have been identified for the tailored treatment of mCRC patients and multiple efforts are currently ongoing to increase the therapeutic options. In the era of precision medicine, molecular-biology-driven treatment is the key to impro patient selection and patient outcomes. Further research and large phase III trials are required to ameliorate the therapeutic management of these patients.
Author
Shelf entry
Permalink
- URL:
Impact factor
Access to the JCR database is permitted only to users from Slovenia. Your current IP address is not on the list of IP addresses with access permission, and authentication with the relevant AAI accout is required.
Year | Impact factor | Edition | Category | Classification | ||||
---|---|---|---|---|---|---|---|---|
JCR | SNIP | JCR | SNIP | JCR | SNIP | JCR | SNIP |
Select the library membership card:
If the library membership card is not in the list,
add a new one.
DRS, in which the journal is indexed
Database name | Field | Year |
---|
Links to authors' personal bibliographies | Links to information on researchers in the SICRIS system |
---|
Source: Personal bibliographies
and: SICRIS
The material is available in full text. If you wish to order the material anyway, click the Continue button.